… Inhaled corticosteroids (ICSs) in combination with long-acting β 2 -agonists (LABAs) reduce
the risk of exacerbations and improve lung function and health status in patients with COPD …

Purpose Asthma is a common disease that is expensive and burdensome for patients.
Inhaled corticosteroids (ICS) are the most important drugs for asthma treatment and are often …

… In conclusion, we found that the regular use of low-dose inhaled corticosteroids is associated
with a decreased risk of death from asthma. This finding has important implications for the …

… Background The role of long-acting β-agonists (LABA) added to inhaled corticosteroids (ICS)
in the management of asthma is extensively debated. We thought to assess the risk of …

… between inhaled corticosteroids and subsequent risk of … between inhaled corticosteroid
therapy and the combined risk of repeat … Patients who received inhaled corticosteroid therapy …

… doses of inhaled corticosteroids, … inhaled corticosteroids in the recent past (7.4 and 8.2%,
respectively). Conclusions: The use of inhaled corticosteroids is associated with an excess risk …

… , as a result of that, wide CIs, we cannot exclude with certainty that especially long-term
exposure with inhaled corticosteroid might be associated with a slightly increased fracture risk. …

… lifetime risk of COPD and asthma is 28% and 35%, respectively [1, 2]. Inhaled corticosteroids
(… Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J …

… The objective of this review is to determine the risk-benefit ratio of inhaled corticosteroid
treatment for COPD by systematically reviewing the evidence on the efficacy, effectiveness, and …

… Since the long-term use of systemic corticosteroids may increase the risk of hypertension
and adrenal suppression, we also wanted to investigate the evidence of a possible increase in …